Clinical Trials Logo

Endocrine Therapy clinical trials

View clinical trials related to Endocrine Therapy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06050109 Recruiting - Clinical trials for Breast Cancer Female

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Start date: September 1, 2023
Phase:
Study type: Observational

To observe and evaluate the clinical efficacy and safety of continuous use of OFS for premenopausal patients with early breast cancer after 5 years use of OFS. This study is a multicenter, prospective, observational, non randomized controlled, open-label real world study based on hospital medical record system data, aimed at evaluating the benefits of continuing to use OFS after 5 years of use. The retrospective analysis plan includes patient data from September 1, 2023 to September 1, 2026. Join two cohorts: the continued use group and the discontinued use group after 5 years of OFS, respectively.

NCT ID: NCT05628077 Recruiting - Breast Cancer Clinical Trials

Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors

Start date: December 30, 2022
Phase:
Study type: Observational

We obtained the occurrence of pain sensation, pain mood, sleep, etc. during endocrine therapy in breast cancer patients through telephone follow-up, and analyzed risk factors through artificial intelligence

NCT ID: NCT05305092 Recruiting - Breast Cancer Clinical Trials

Assessment of Brain Cognitive Impairment in Breast Cancer

Start date: May 31, 2022
Phase:
Study type: Observational

To explore the cognitive impairment caused by chemotherapy and endocrine therapy in premenopausal breast cancer patients and to find biomarkers with early predictive effect on this cognitive impairment by using multimodal integrated PET/MRI technology combined with psychobehavioral technology.

NCT ID: NCT04389424 Recruiting - Breast Cancer Clinical Trials

Relationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast Cancer

NUTRIBREAST
Start date: September 1, 2017
Phase:
Study type: Observational

The protocol involves measurement of 25 hidroxy vitamin D, gene expression of cytochrome and vitamin D receptor , endoxifen, tamoxifen, exemestane, and other metobolites related to nutrition and endocrine metabolism.